Corbus Pharmaceuticals Holding reports a Return on Equity (ROE) of -66.90%.

What is CRBP's dividend yield?

Corbus Pharmaceuticals Holding offers a dividend yield of 0.00%.

What is CRBP's Quality Score?

Our AI rates CRBP's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CRBP?

Our AI Timing Score for CRBP is 96 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CRBP belong to?

Corbus Pharmaceuticals Holding is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Corbus Pharmaceuticals Holding (CRBP) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

CRBP AI Analysis Summary

Our AI summary for CRBP: Corbus Pharmaceuticals Holding (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -66.90%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 96/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CRBP

Corbus Pharmaceuticals Holding

US:NASDAQ STOCK Healthcare >> Biotechnology News 76

USD 9.57

0.17 (1.81%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-66.9%

ROE

-58.5%

ROA

0.00%

Div Yield

CORBUS PHARMACEUTICALS HOLDING
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 9.57 Price 0.17 (1.81%) Day Change	NEWS SCORE: 76

CRBP, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	76
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	9.57
PBV / Sector	1.38 / 44,105.10 GOOD
Earning Per Share	-4.64

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	2.27 M GREAT
Average 1W Daily Value	2.06 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-58.50 / 185,260.64
ROA Average (%) / Sector	-74.59 / 36,684.64
ROA Change Average (%) / Sector	27.51 / 422,221.42 GREAT
ROE (%) / Sector	-66.90 / 243,761.81
ROE Average (%) / Sector	65.67 / 48,758.38 GREAT
ROE Change Average (%) / Sector	-117.95 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 07:59:49
Symbol	CRBP
Name	CORBUS PHARMACEUTICALS HOLDING
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	18.53 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	174.16 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 500 River Ridge Drive, Norwood, MA, United States, 02062

Phone: 617 963 0100

Website: https://www.corbuspharma.com

Sector: Healthcare >> Biotechnology

Description: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.